|
151 |
Safety and pharmacokinetics evaluation of oroxylin A in Chinese healthy volunteers: a phase I, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect study
Enthalten in Clinical and translational oncology 3.9.2025: 1-14
|
|
|
|
152 |
SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine: A Pilot Multicenter Randomized Placebo-Controlled Trial
Enthalten in Neurocritical care 28.8.2025: 1-13
|
|
|
|
153 |
The Effect of Lactobacillus Acidophilus (La5) on the Incidence of Urinary Tract Infection in the Puerperium: A Randomized Placebo-Controlled Trial
Enthalten in Probiotics and Antimicrobial Proteins 27.8.2025: 1-13
|
|
|
|
154 |
Effects of orally administered cetylated fatty acids on symptoms and functional capacity in patients with knee osteoarthritis: results of a randomized, double-blind, placebo-controlled study
Enthalten in European journal of clinical nutrition 25.8.2025: 1-6
|
|
|
|
155 |
Design of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Enthalten in American journal of perinatology 20.08.2025
|
|
|
|
156 |
A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 18.8.2025: 1-14
|
|
|
|
157 |
Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 18.8.2025: 1-13
|
|
|
|
158 |
Impact of royal jelly consumption on oxidative stress, anti-oxidant markers and physical activities of patients with multiple sclerosis: a randomized double-blind placebo-controlled study
Enthalten in Irish journal of medical science 18.8.2025: 1-12
|
|
|
|
159 |
Response to Letter to the Editor: Effect of BCG vaccination on immune-regulatory markers and glycemic control in children with new-onset type 1 diabetes mellitus (T1DM): a randomised double-blinded placebo-controlled pilot trial
Enthalten in International journal of diabetes in developing countries 18.8.2025: 1-2
|
|
|
|
160 |
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
Enthalten in Psychopharmacology 16.8.2025: 1-11
|
|
Administration
